Business Context and Reporting Period
Company: MARTIN MIDSTREAM PARTNERS L.P. (MMLP)
Filing Type: Form 8-K (Current Report)
Date of Report: October 3, 2024
Event: Entry into a Material Definitive Agreement (Agreement and Plan of Merger).
On October 3, 2024, Martin Resource Management Corporation ("Parent") and its subsidiary, MRMC Merger Sub LLC ("Merger Sub"), entered into an Agreement and Plan of Merger with Martin Midstream Partners L.P. (the "Partnership") and its General Partner. Under the agreement, Merger Sub will merge with and into the Partnership, with the Partnership surviving as a wholly owned subsidiary of Parent.
Key Financial Metrics and Transaction Terms
Merger Consideration: Each outstanding Public Common Unit will be converted into the right to receive $4.02 in cash per unit without interest.
Excluded Units: Common Units owned by Parent and its subsidiaries (including the General Partner) will not be cancelled or converted and will remain outstanding.
Equity Vesting: All restricted units, phantom units, and phantom unit appreciation rights will fully vest immediately prior to the effective time of the Merger, with holders receiving the Merger Consideration for each vested unit.
Funding Sources: Parent expects to fund the transaction through existing cash on hand, cash flow, borrowings under its existing credit facility (including an expected increase in revolving commitments and a new term loan), and $5,000,000 in loans from certain members of Parent's management team.
Material Changes and Support Agreements
Support Agreements: Concurrent with the Merger Agreement, Parent and certain significant unitholders entered into Support Agreements to vote their units in favor of the Merger. Key holders include:
- Parent and subsidiaries: 6,114,532 Common Units (~15.7% of outstanding).
- Senterfitt Holdings Inc.: 3,726,607 Common Units (~9.56% of outstanding).
- Ruben S. Martin III (RSM): ~159,350 Common Units (~0.41% of outstanding).
- Robert D. Bondurant: ~149,296 Common Units (~0.38% of outstanding).
Board Approval: The GP Conflicts Committee and the GP Board unanimously determined the Merger is fair and reasonable, approved the agreement, and recommended it for a vote by the limited partners.
Guidance, Outlook, Risks, and Contingencies
Conditions to Closing: Completion is subject to customary conditions, including:
- Approval by holders of a majority of issued and outstanding Common Units.
- Expiration or termination of applicable antitrust waiting periods.
- No laws or injunctions prohibiting the transaction.
- Accuracy of representations and warranties.
Termination Rights and Fees:
- Outside Date: The Merger must be consummated by March 31, 2025, or it may be terminated.
- Termination Fees:
- If terminated under certain circumstances, the Partnership may pay Parent a fee of $2,500,000.
- If terminated under other circumstances, Parent may pay the Partnership a fee of $6,000,000.
- Expense reimbursement caps are set at $5,000,000 for each party.
Risks and Forward-Looking Statements: The filing highlights risks regarding the ability to consummate the transaction, funding availability, regulatory approvals, unitholder approval, operational disruption, and litigation. The filing does not provide specific financial guidance for future periods beyond the transaction terms.
Important Facts for Investor Verification
- Offer Price: Verify the $4.02 per unit cash consideration against current market prices and historical trading ranges.
- Approval Requirement: Confirm the requirement for a majority vote of outstanding Common Units to approve the Merger.
- Financing Certainty: Review the Parent's credit facility terms and the status of the $5 million management loans to ensure funding is secured.
- Termination Triggers: Monitor for any "Superior Proposal" or "Intervening Event" that could trigger a change in the GP Conflicts Committee's recommendation or allow Parent to terminate.
- Upcoming Documents: Await the filing of the Proxy Statement and Schedule 13E-3 for detailed financial analysis and voting instructions.